2019年9月 | サターラ

Blog

Health Canada PRCI Guiding Principles and Observations

Health Canada released guidance on 2019年3月12日 pertaining to its Public Release of Clinical…

Certara2019年9月16日

Poster

A Population-based PBPK Model for the Prediction of Time-varying Bile Salt Disposition within GI Luminal Fluids – Toward a Mechanistic Model

Danielle Pillsbury2019年9月4日

Poster

Development of a PBPK model for topical lidocaine in order to predict systemic absorption in healthy volunteers, geriatrics and paediatrics

Danielle Pillsbury2019年9月4日

Poster

Predicting the Concentration of PARP Inhibitors in Human Tumor Tissue Using PBPK Modeling

Danielle Pillsbury2019年9月4日

Poster

Performance Verification and Application of a Cancer population for use in Physiologically Based Pharmacokinetic modelling

Danielle Pillsbury2019年9月4日

Poster

Evaluation of maternal drug exposure following the administration of antenatal corticosteroids during late pregnancy using PBPK Modeling

Danielle Pillsbury2019年9月4日

Poster

INVESTIGATING THE IMPACT OF ENZYME CORRELATIONS ON INTER-INDIVIDUAL VARIABILITY IN PHARMACOKINETICS AND DRUG-DRUG INTERACTIONS

Danielle Pillsbury2019年9月4日

Poster

Biokinetic and PBPK modelling to support the rotenone and strobilurin read across case studies (CS4)

Danielle Pillsbury2019年9月4日

Poster

Biokinetic and PBPK Modelling to Support Read-Across Assessment of Repeat Dose and Developmental and Reproductive Toxicity of Valproic Acid Analogues

Danielle Pillsbury2019年9月4日

Poster

Physiologically Based Pharmacokinetic/Pharmacodynamic model of gastrointestinal toxicity induced by 5-fluorouracil in mouse and translation to human

Danielle Pillsbury2019年9月4日

© 2025 Certara. All Rights Reserved. | 個人情報保護

Powered by Translations.com GlobalLink Web Software